Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel Era”: data from 917 patients in the control arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) - James, N D; Spears, M R; Clarke, N W (European urology, 2015)
et al.